{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T15:58:53Z","timestamp":1767974333815,"version":"3.49.0"},"reference-count":34,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"unspecified","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Patients with kidney failure receiving chronic haemodialysis have elevated risk of arrhythmias potentially increasing the likelihood of sudden cardiac death, stroke and hospitalisation. The DIALIZE study (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03303521\">NCT03303521<\/jats:ext-link>) demonstrated that sodium zirconium cyclosilicate (SZC) was an efficacious and well-tolerated treatment for predialysis hyperkalaemia in patients undergoing haemodialysis. The DIALIZE-Outcomes study evaluates the effect of SZC on sudden cardiac death and arrhythmia-related cardiovascular outcomes in patients receiving chronic haemodialysis with recurrent hyperkalaemia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p>International, multicentre, randomised, double-blind, placebo-controlled study conducted at 357 study sites across 25 countries. Adults (\u226518 years) receiving chronic haemodialysis three times per week with recurrent predialysis serum potassium (K<jats:sup>+<\/jats:sup>) \u22655.5 mmol\/L post long interdialytic interval (LIDI) are eligible. Patients (~2800) will be randomised 1:1 to SZC or placebo, starting at 5 g orally once daily on non-dialysis days and titrated weekly in 5 g increments (maximum 15 g) to target predialysis serum K<jats:sup>+<\/jats:sup>4.0\u20135.0 mmol\/L post LIDI. The primary objective is to evaluate efficacy of SZC versus placebo in reducing occurrence of the primary composite endpoint of sudden cardiac death, stroke or arrhythmia-related hospitalisation, intervention or emergency department visit. Secondary endpoints include efficacy of SZC versus placebo in maintaining normokalaemia (serum K<jats:sup>+<\/jats:sup>4.0\u20135.5 mmol\/L post LIDI) at the 12-month visit, preventing severe hyperkalaemia (serum K<jats:sup>+<\/jats:sup>\u22656.5 mmol\/L post LIDI) at the 12-month visit and reducing the incidence of individual cardiovascular outcomes. Safety of SZC will be evaluated. The study is event driven, with participants remaining in the study until 770 primary endpoint events have occurred. Average time in the study is expected to be ~25 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>Approval was obtained from the relevant institutional review board\/independent ethics committee from each participating site (approving bodies in supplementary information). The results will be submitted to a peer-reviewed journal.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration numbers<\/jats:title><jats:p>EudraCT 2020-005561-14 and clinicaltrials.gov identifier<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04847232\">NCT04847232<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2022-071309","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T17:26:49Z","timestamp":1685035609000},"page":"e071309","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of the effect of sodium zirconium cyclosilicate on arrhythmia-related cardiovascular outcomes in patients receiving chronic haemodialysis with hyperkalaemia: protocol for the multicentre, randomised, controlled DIALIZE-Outcomes study"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct03303521","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04847232","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03303521","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04847232","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2238-8574","authenticated-orcid":false,"given":"Steven","family":"Fishbane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Jadoul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Dember","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CP","family":"Kovesdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Al-Shurbaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Lisovskaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Sekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Katona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"key":"2023052510252047000_13.5.e071309.1","unstructured":"United States Renal Data System . 2021 USRDS annual data report: mortality. 2021. Available: https:\/\/adr.usrds.org\/2021\/end-stage-renal-disease\/6-mortality [Accessed 22 Aug 2022]."},{"key":"2023052510252047000_13.5.e071309.2","unstructured":"The World Bank . Death rate, crude (per 1,000 people). 2022. Available: https:\/\/data.worldbank.org\/indicator\/SP.DYN.CDRT.IN [Accessed 14 Sep 2022]."},{"key":"2023052510252047000_13.5.e071309.3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.050686"},{"key":"2023052510252047000_13.5.e071309.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103313"},{"key":"2023052510252047000_13.5.e071309.5","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00391.x"},{"key":"2023052510252047000_13.5.e071309.6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.00806.x"},{"key":"2023052510252047000_13.5.e071309.7","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.08850811"},{"key":"2023052510252047000_13.5.e071309.8","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.22"},{"key":"2023052510252047000_13.5.e071309.9","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.kint.2017.11.019","article-title":"Primary outcomes of the monitoring in dialysis study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle","volume":"93","author":"Roy-Chaudhury","year":"2018","journal-title":"Kidney Int"},{"key":"2023052510252047000_13.5.e071309.10","unstructured":"Centers for Disease Control and Prevention . Leading causes of death. 2022. Available: https:\/\/www.cdc.gov\/nchs\/fastats\/leading-causes-of-death.htm [Accessed 6 Jun 2022]."},{"key":"2023052510252047000_13.5.e071309.11","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp104"},{"key":"2023052510252047000_13.5.e071309.12","unstructured":"United States Renal Data System . 2019 USRDS annual data report. 2019. Available: https:\/\/www.usrds.org\/annual-data-report [Accessed 30 May 2022]."},{"key":"2023052510252047000_13.5.e071309.13","doi-asserted-by":"crossref","unstructured":"Tumlin JA , Roy-Chaudhury P , Koplan BA , et al . Relationship between dialytic parameters and reviewer confirmed arrhythmias in hemodialysis patients in the monitoring in dialysis study. BMC Nephrol 2019;20:80. doi:10.1186\/s12882-019-1212-6","DOI":"10.1186\/s12882-019-1212-6"},{"key":"2023052510252047000_13.5.e071309.14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00101.x"},{"key":"2023052510252047000_13.5.e071309.15","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft276"},{"key":"2023052510252047000_13.5.e071309.16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.ajkd.2016.10.024","article-title":"Serum potassium and short-term clinical outcomes among hemodialysis patients: impact of the long interdialytic interval","volume":"70","author":"Brunelli","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"2023052510252047000_13.5.e071309.17","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.481"},{"key":"2023052510252047000_13.5.e071309.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2015.06.033"},{"key":"2023052510252047000_13.5.e071309.19","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04451206"},{"key":"2023052510252047000_13.5.e071309.20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000448341","article-title":"Serum potassium levels and mortality in hemodialysis patients: a retrospective cohort study","volume":"44","author":"Yusuf","year":"2016","journal-title":"Am J Nephrol"},{"key":"2023052510252047000_13.5.e071309.21","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01730215"},{"key":"2023052510252047000_13.5.e071309.22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1053\/j.ajkd.2016.09.015","article-title":"Dialysate potassium, serum potassium, mortality, and arrhythmia events in hemodialysis: results from the dialysis outcomes and practice patterns study (DOPPS)","volume":"69","author":"Karaboyas","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"2023052510252047000_13.5.e071309.23","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.07.044"},{"key":"2023052510252047000_13.5.e071309.24","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s40620-020-00880-4","article-title":"Large potassium shifts during dialysis enhance cardiac repolarization instability","volume":"34","author":"Sch\u00fcttler","year":"2021","journal-title":"J Nephrol"},{"key":"2023052510252047000_13.5.e071309.25","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/ki.1980.93","article-title":"Mechanism and prevention of cardiac arrhythmias in chronic hemodialysis patients","volume":"17","author":"Morrison","year":"1980","journal-title":"Kidney Int"},{"key":"2023052510252047000_13.5.e071309.26","doi-asserted-by":"crossref","unstructured":"Natale P , Palmer SC , Ruospo M , et al . Potassium binders for chronic hyperkalaemia in people with chronic kidney disease. Cochrane Database Syst Rev 2020;6. doi:10.1002\/14651858.CD013165.pub2","DOI":"10.1002\/14651858.CD013165.pub2"},{"key":"2023052510252047000_13.5.e071309.27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1159\/000504078","article-title":"Efficacy and safety of sodium zirconium cyclosilicate for treatment of hyperkalemia: an 11-month open-label extension of harmonize","volume":"50","author":"Roger","year":"2019","journal-title":"Am J Nephrol"},{"key":"2023052510252047000_13.5.e071309.28","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.12651018"},{"key":"2023052510252047000_13.5.e071309.29","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2019050450"},{"key":"2023052510252047000_13.5.e071309.30","first-page":"187","article-title":"Atrial fibrillation in the UK: Predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs","volume":"8","author":"Burdett","year":"2022","journal-title":"Ehj-Qcco"},{"key":"2023052510252047000_13.5.e071309.31","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-G\u00f3mez JM , Villaverde M , Jofre R , et al . Interdialytic weight gain as a marker of blood pressure, nutrition, and survival in hemodialysis patients. Kidney Int Suppl 2005:S63\u20138. doi:10.1111\/j.1523-1755.2005.09314.x","DOI":"10.1111\/j.1523-1755.2005.09314.x"},{"key":"2023052510252047000_13.5.e071309.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.12.048"},{"key":"2023052510252047000_13.5.e071309.33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12882-016-0293-8","article-title":"Incidence of sudden cardiac death in adults with end-stage renal disease: a systematic review and meta-analysis","volume":"17","author":"Ramesh","year":"2016","journal-title":"BMC Nephrol"},{"key":"2023052510252047000_13.5.e071309.34","doi-asserted-by":"publisher","DOI":"10.1046\/j.1542-474X.2003.08413.x"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-071309","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T17:28:04Z","timestamp":1685035684000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-071309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5,25]]},"published-print":{"date-parts":[[2023,5]]}},"alternative-id":["10.1136\/bmjopen-2022-071309"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-071309","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5]]}}}